雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Study on Medical Economic Evaluation Methods for Metastatic Brain Tumors Therapy Tomoyuki TAKURA 1 , Motohiro HAYASHI 2 , Yoshihiro MURAGAKI 2 , Hiroshi ISEKI 2 , Yoshio UETSUKA 3 1Medical Center for Translational Research,Osaka University Faculty of Medicine 2Department of Neurosurgery,Neurological Institute,Graduate School of Medicine,Tokyo Women's Medical University 3Department of Hospital Administration,Graduate School of Medicine,Tokyo Women's Medical University Keyword: medical economic evaluation , cost effectiveness analysis , Qalys , gamma knife , peripheral dose pp.629-637
Published Date 2010/7/10
DOI https://doi.org/10.11477/mf.1436101210

閲覧方法のご案内

この論文を閲覧するためにはログインが必要になります。
パスワードを忘れた場合 新しくユーザー登録する 施設共通IDをご利用の方はこちらから

PPV購入案内

1,320円 (1,200円+税10%) こちらは、629ページから637ページの文献です。
PPV(ペイ・パー・ビュー)とは、論文(記事)単位で購入・閲覧ができるサービスです。
購入には医書.jp本会員登録が必要です。



会員登録完了後に改めて上記「購入サイトへ」を選択してください。
または「購入サイトへ」選択後に「購入ログイン」、「新規会員登録」の順に進んでください。

会員登録について詳しくはをご確認ください。
  • Abstract
  • Look Inside
  • Reference

 Introduction: Treatment design for metastatic brain tumors is required to firstly care about the life and function for which the patient hopes because it is terminal care. Therefore,to discuss the value of the therapy,a viewpoint of the QOL and the socioeconomic factors other than the survival rate is important. However,examination that applies these factors to the therapy needs to be carried out more thoroughly. With this in mind,we discuss cost effectiveness of therapy for metastatic brain tumor,through a pilot study on gamma knife therapy.

 Materials and method: We studied 18 patients (mean age 61.6 years old) undergoing therapy for metastatic brain tumors. The health rate QOL was assessed by the profile-type measure SF-36 (Short-Form 36-Item Ver1.2) and the preference-based measure EQ-5D (EuroQoL-5D), before and six months after gamma knife therapy. Cost-utility-analysis (yen/Qaly) was carried out from quality adjusted life years (Qalys) and medical fee claims. In addition, we made a correlation analysis of the irradiation procedure and the gains attained.

 Results: The observation by SF-36 for six months was useful for metastatic brain tumor. As a result, the QOL indicators showed increased mental health (MH: p=0.040) and role emotional (RE: p=0.029) with significant difference. In the measurement of EQ-5D, it was added only for one month based on the significant difference (p=0.022) from the pre-therapy QOL. The utilities that were analyzed became 0.052±0.175SD (score), and Qalys were 0.135. Because the cost was 721.4±5.2SD (thousand yen), the performance of cost-utility-analysis was estimated as 5,330,000 (yen/Qaly). In addition, positive correlation (r=0.845/p=0.034) was found between the EQ-5D utility score and the tumor irradiation energy (mJ), etc.

 Conclusion: We established a new value over and above mere survival rate concerning metastatic brain tumor therapy. The socioeconomics and efficacy of therapy are more difficult to discuss in this disease than in other diseases. We did this by clarifying the measurement and analysis of QOL as compared with the cost factor. We found that quantitatively,the mental health rate involved in the QOL,had improved. We established that it is appropriate to cover this disease by public insurance,because cost-utility-analysis showed that it was under the threshold line. Our study also suggested that,when guessing the QOL of the prognosis,there should be grades of sensitivity according to the irradiation element involved in the therapy.


Copyright © 2010, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1251 印刷版ISSN 0301-2603 医学書院

関連文献

もっと見る

文献を共有